Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Eric, van Roon"'
Autor:
Darko Mitrovic, Margriet van Elp, Loes Visser, Nienke van Rein, Patricia van den Bemt, Marinus van Hulst, Albert Dreijer, Heleen Lameijer, Nic Veeger, Karina Meijer, Eric van Roon
Publikováno v:
Current Medical Research and Opinion. :1-7
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Objectives Patients with allergic rhinitis receive their information about administering intranasal corticosteroid sprays (INCS) from healthcare workers. Since the majority of patients does not administer these sprays correctly, we investigated wheth
Externí odkaz:
https://doaj.org/article/9db5fa6dab34445eb44384c511ea2a1d
Publikováno v:
Current Medical Research and Opinion, 39(1), 71-79. Taylor & Francis Ltd
OBJECTIVE: To investigate and describe the protocolized treatment of DOAC-related bleeds in all Dutch hospitals.METHODS: From August to December 2020 a nationwide survey among all 70 hospitals in the Netherlands was conducted on their protocols for m
Publikováno v:
Current Medical Research and Opinion, 39(1), 13-18. Taylor & Francis Ltd
Objectives: To investigate and describe the protocolized perioperative management in patient using Direct oral anticoagulants (DOACs) in Dutch hospitals.Methods: Between August and December 2020, a nationwide survey in 70 hospitals in the Netherlands
Autor:
Darko Mitrovic, Wouter Emmens, Achraf Naimi, Annerose van der Mijle, Nic Veeger, Eric van Roon, Patricia van den Bemt
Publikováno v:
Clinical Drug investigation, 42, 593-598. ADIS INT LTD
BACKGROUND AND OBJECTIVE: Several cases of venous thromboembolism in patients treated with direct oral anticoagulants (DOACs) have been reported in the literature, but a quantative analysis of postmarketing reports is lacking. The objective of this s
Autor:
Johanne Rozema, Jetske Graafsma, Mels Hoogendoorn, Robby Kibbelaar, Nic Veeger, Eric van Roon
Publikováno v:
Journal of Geriatric Oncology, 14(2):101418. ELSEVIER SCIENCE BV
INTRODUCTION: Treatment for myelodysplastic syndromes (MDS) is complex, options are limited, and insight into consecutive treatments is lacking. We performed this study to assess the outcomes in a real-world cohort of patients with MDS.MATERIALS AND
Autor:
Johanne Rozema, Eric van Roon, Lars Vogelzang, Robby Kibbelaar, Nic Veeger, Arjan van de Loosdrecht, Mels Hoogendoorn
Publikováno v:
Rozema, J, van Roon, E, Vogelzang, L, Kibbelaar, R, Veeger, N, van de Loosdrecht, A & Hoogendoorn, M 2022, ' Management of infection prophylaxis in Dutch patients with myelodysplastic syndromes, a web-based case vignette questionnaire : The MINDSET study ', European Journal of Haematology, vol. 109, no. 4, pp. 381-387 . https://doi.org/10.1111/ejh.13820
European Journal of Haematology, 109(4), 381-387. Wiley
European Journal of Haematology, 109(4), 381-387. Wiley-Blackwell
European Journal of Haematology, 109(4), 381-387. Wiley
European Journal of Haematology, 109(4), 381-387. Wiley-Blackwell
OBJECTIVES: Infections are a major cause of morbidity and mortality in patients with myelodysplastic syndromes (MDS). The objective of the MINDSET study was to evaluate haematologists' management of infection prevention in MDS patients using a case v
Publikováno v:
Current Medical Research and Opinion, 38(9). Taylor & Francis Ltd
OBJECTIVE: In a previous study on the reasons for discontinuation of novel oral anticoagulation therapy (NOAC) in patients with atrial fibrillation, we showed that minor bleeding was the second most important reason for NOAC discontinuation. This fin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deaa5198d4a48bcc852522bc9695ea57
Publikováno v:
Haematologica, Vol 99, Iss 2 (2014)
Externí odkaz:
https://doaj.org/article/a628231d74034bf884ed25239b5b193c
Autor:
Kim, van der Elst, Berdien, Oortgiesen, Willemien, Kruik-Kollöffel, Mels, Hoogendoorn, Sjoerd, Hofma, Eric, van Roon
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 163
Rationale When patients are using carbasalate calcium or acetylsalicylic acid (ASA), it is recommended to prescribe a proton pump inhibitor (PPI) in order to prevent gastrointestinal (GI) bleeding. Should this recommendation also be followed for pati